Browse studies

Find your next paid study

3,845 recruiting studies matching your filters

Immuno-PET Imaging of Neuroendocrine Tumors Using 89Zr-DFO-SC16.56, a DLL3-targeting Monoclonal Antibody

The purpose of this study is to look at how safe 89Zr-DFO-SC16.56 is, and how it is processed by the body in people with small cell lung cancer.

Small Cell Lung CancerSmall Cell Lung Carcinoma

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT04199741

Phase 2

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

This clinical research study is to learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy for cancer survivors with depression a…

DepressionAnxietyCancer

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT06801041

Observational

A Personalized Approach to Promote Health Equity by Overcoming Racial Disparities in Screening Mammography

The purpose of this study is to increase screening mammography among Black women by implementing and evaluating a culturally tailored patient-centric program d…

Breast CancerCancer of the Breast

Estimated

~$10 – $6,250

Washington University School of MedicineNCT07549139

Phase 3

A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator's Choice of Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

This is a randomized, Phase 3 trial designed to evaluate the efficacy and safety of azenosertib compared to Investigator's choice of chemotherapy in subjects w…

Ovarian Cancer

Estimated

~$10 – $8,750

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, IncNCT07546500

Phase 2

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

This is an open-label, dose escalation and expansion, multi-center phase 2 study evaluating the safety and efficacy of SR-8541A administered orally in combinat…

Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Estimated

~$10 – $8,750

Stingray TherapeuticsNCT06589440

Phase 2

Balancing Radiation Intensification and Quality of Life in Higher-Risk Prostate Cancer (The BALANCE-RT Trial)

The purpose of the study is to explore the best ways of giving radiation therapy to balance cancer control and treatment side effects.

Prostate Cancer PatientsNon-metastatic Prostate CancerHigh Risk Prostate Cancer

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07751159

Phase 1

A Prospective Cohort Study of Integrating Radiotherapy Into Chemotherapy With Pembrolizumab and Bevacizumab in Newly Diagnosed Stage IVB Cervical Cancer

This phase I/II trial tests the safety and effectiveness of receiving external beam radiation therapy (EBRT) and brachytherapy along with chemotherapy, consist…

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+1 more

Estimated

~$10 – $6,250

Jonsson Comprehensive Cancer CenterNCT06543576

Observational

Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention

The goal of this research study is to learn about the effects of the RISE-YA intervention on cancer-related fatigue in young adults who are brain cancer surviv…

CancerFatigueBrain Tumor Adult

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07186556

Observational

Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

Inspired by the ongoing Pink \& Pearl Campaign, the breast radiology service of Christian Hospital in north St. Louis County will partner with Siteman Cancer C…

Lung CancerCancer of the Lung

Estimated

~$10 – $6,250

Washington University School of MedicineNCT07146568

Phase 4

A Phase IV Master Protocol of Cosibelimab in Special Populations With Advanced Cutaneous Squamous Cell Carcinoma (CosiMaster)

This is study is to evaluate the safety and efficacy of cosibelimab in special populations with advanced cutaneous squamous cell carcinoma (CSCC). The name of…

Cutaneous Squamous Cell CarcinomaSkin Cancer

Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT07426484

Phase 1

A Phase 1/1b First-in-Human, Open Label, Dose Escalation and Cohort Expansion Study of MGC026 in Participants With Advanced Solid Tumors

The study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants wi…

Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more

Estimated

~$10 – $7,500

MacroGenicsNCT06242470

Phase 1

Combination Of Izalontamab Brengitecan And Adagrasib In Advanced KRAS G12Ci-Refractory Non-Small Cell Lung Cancer - The IZA-A Trial

This research is being done to test a combination of two drugs, Izalontamab Brengitecan (iza-bren) and Adagrasib, in patients with advanced KRAS G12C-mutant NS…

Non-small Cell Lung Cancer

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07382726